Genomenon Extends Insight into Genomic Evidence with Mastermind Search Companion

FOR IMMEDIATE RELEASE
November 30, 2021 Ann Arbor, Michigan

Genomenon Extends Insight into Genomic Evidence with Mastermind Search Companion

Free Google Chrome Extension to 14 Variant Databases Accelerates Genomic Interpretation and Research

Genomenon, Inc.®, an AI-driven genomics company, today announced the new Mastermind Search Companion, a Google Chrome browser plug-in for use with 14 variant databases, Google, and Google Scholar. The free extension, available through the Chrome Web Store to all Google Chrome users enables deeper insight into genetic evidence related to searches across a wide range of variant databases used by geneticists, genetic counselors, variant scientists, and researchers.

Mastermind Search Companion seamlessly integrates Mastermind’s insight into the scientific literature with the online resources variant analysts already use. Because Mastermind has 100X more genomic evidence than any other source, the extension provides in-platform access to additional genetic data for genes and variants searched on any of the following platforms: ClinVar, HGMD, dbSNP, old dbSNP, OMIM, COSMIC, CIViC, UCSC Browser, Google Scholar, Google, VarSome, GeneCards, NCBI, Gnomad, SNPedia, and OncoKB.

Users of the extension will find an optimized visual display with an interactive sliding drawer tab which contains helpful information and direct links to the prioritized genomic evidence within Mastermind. This allows analysts to quickly navigate their standard search sites and expand them with Mastermind search results. Mastermind Search Companion delivers the ability to get more insight within any existing process and set of databases.

"Genomenon’s Search Companion extends Mastermind’s support into additional variant databases for everyone tasked with interpreting genomic data,” said Mike Klein, Genomenon CEO. “Most importantly, the plug-in will provide insight into the scientific evidence required to interpret patient variants to clinical guidelines."

Genomenon’s Mastermind supports variant interpretation efforts for cancer and genetic disease by using an AI-driven approach to connect patient genetic data with relevant evidence from scientific literature. As the world’s most comprehensive source for genomic literature in the variant interpretation space, Mastermind is used by over 1,000 diagnostic labs and integrated into 18 clinical-grade decision support platforms and reference databases across the globe.

Mastermind Search Companion is available to all Chrome users at no cost. A Mastermind account is not required for use. Download Mastermind Search Companion.

About
Genomenon

The Real-world Evidence to validate a drug target, identify trial-eligible patients, or change a diagnosis already exists. It is buried in 39 million biomedical articles, locked behind paywalls and supplemental files most researchers never find.

Genomenon closes that gap. Fit-for-purpose AI-powered search reads 11.2 million full-text papers and 3.7 million supplemental datasets. Eighty expert scientific curators validate every finding. The result is structured, traceable, regulatory-grade Real-World Evidence at the genetic variant and patient level. Loxo@Lilly used Genomenon to add 73 variants to the RET label. In a head-to-head, Genomenon identified 83% more rare disease patients than ChatGPT plus OpenEvidence.

250+ diagnostic labs and 75 biopharma programs rely on Genomenon as the evidence layer behind precision medicine.

About
Mastermind (square)
Read the Article
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.